Physician profile
Mona Mikhail
NPI 1467416784
$7,338.76
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,259 · 2020: $2,129 · 2021: $1,729 · 2024: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $1,592.27 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $1,032.38 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $830.20 | 2019-2021 | |
| Bausch Health US, LLC | $712.17 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $644.54 | 2019-2021 | |
| Allergan, INC. | $533.61 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $425.96 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $420.59 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $199.48 | 2019-2024 | Fanapt |
| Teva Pharmaceuticals USA, INC. | $170.48 | 2019-2021 | |
| Eisai INC. | $152.28 | 2020-2021 | |
| Abbvie INC. | $132.03 | 2021 | |
| Neurocrine Biosciences, INC. | $116.14 | 2019 | |
| Alkermes, INC. | $114.30 | 2024 | Lybalvi |
| Neos Therapeutics, Lp | $79.30 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $58.26 | 2019 | |
| Adlon Therapeutics L.P. | $41.32 | 2019-2021 | |
| Alfasigma USA, INC. | $27.91 | 2020 | |
| Shire North American Group INC | $21.06 | 2019 | |
| Neuronetics, INC. | $18.39 | 2019 | |
| Arbor Pharmaceuticals, INC. | $16.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Mikhail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.